Chongqing Medical University, previously referred to as the Chongqing University of Medical Sciences, was established in 1956 in Chongqing, China. It was originally a branch of the Shanghai First Medical College.

During the past decade, The Second Affiliated Hospital of Chongqing Medical University conducted 78 clinical trials. In the 10-year time frame, 78 clinical trials started and 8 clinical trials were completed, i.e. on average, 10.3% percent of trials that started reached the finish line to date. In the past 5 years, 54 clinical trials started and 5 clinical trials were completed. i.e. 9.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Second Affiliated Hospital of Chongqing Medical University" #1 sponsor was "The Second Affiliated Hospital of Chongqing Medical University" with 22 trials, followed by "Chia Tai Tianqing Pharmaceutical Group Co., Ltd." with 7 trials sponsored, "Nanfang Hospital of Southern Medical University" with 7 trials sponsored, "Hoffmann-La Roche" with 4 trials sponsored and "Takeda" with 4 trials sponsored. Other sponsors include 42 different institutions and companies that sponsored additional 39 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Second Affiliated Hospital of Chongqing Medical University" #1 collaborator was "The Second Affiliated Hospital of Chongqing Medical University" with 9 trials as a collaborator, "LanZhou University" with 3 trials as a collaborator, "Major Science and Technology Special Project of China Eleventh Five-year" with 3 trials as a collaborator, "Novartis" with 3 trials as a collaborator and "The First Hospital of Jilin University" with 3 trials as a collaborator. Other collaborators include 256 different institutions and companies that were collaborators in the rest 233 trials.

According to Clinical.Site data, the most researched conditions in "The Second Affiliated Hospital of Chongqing Medical University" are "Hepatitis B, Chronic" (8 trials), "Type 2 Diabetes" (4 trials), "Chronic Hepatitis B" (3 trials), "Hemophilia A" (3 trials) and "Hepatocellular Carcinoma" (3 trials). Many other conditions were trialed in "The Second Affiliated Hospital of Chongqing Medical University" in a lesser frequency.

Most popular intervention types in "The Second Affiliated Hospital of Chongqing Medical University" are "Drug" (56 trials), "Device" (7 trials), "Other" (7 trials), "Biological" (6 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Lansoprazole" (4 trials), "Lansoprazole Placebo" (4 trials), "Bismuth-Containing Quadruple Therapy" (2 trials) and "Carboplatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "The Second Affiliated Hospital of Chongqing Medical University" are 87 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are 43 active trials in "The Second Affiliated Hospital of Chongqing Medical University". 5 are not yet recruiting, 27 are recruiting, 10 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 31 completed trials in The Second Affiliated Hospital of Chongqing Medical University, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in The Second Affiliated Hospital of Chongqing Medical University, 3 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 13 trials, and there were also 8 trials that are defined as “Not Applicable".